Observational analysis reveals enhanced quality of life and hemodynamics in heart failure patients with LVAD, suggesting a potential for better management.
Key Points
LVAD implantation improved hemodynamics and quality of life in patients with heart failure, but mortality remained unchanged.
Mortality rates were comparable between LVAD patients at 30.4% and non-surgical patients at 30%.
Echocardiographic assessments and biomarkers showed significant improvements after LVAD implantation, indicating better heart function.
Hospitalization rates decreased from 37 to 23 in patients receiving LVAD, suggesting potential benefits for management of heart failure.